134 related articles for article (PubMed ID: 17324439)
1. Quantifying tumour-infiltrating lymphocyte subsets: a practical immuno-histochemical method.
Loughlin PM; Cooke TG; George WD; Gray AJ; Stott DI; Going JJ
J Immunol Methods; 2007 Apr; 321(1-2):32-40. PubMed ID: 17324439
[TBL] [Abstract][Full Text] [Related]
2. Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining.
Schwarz S; Butz M; Morsczeck C; Reichert TE; Driemel O
J Oral Pathol Med; 2008 Sep; 37(8):485-9. PubMed ID: 18355177
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: relation to prognostic variables.
Helal TE; Ibrahim EA; Alloub AI
Indian J Pathol Microbiol; 2013; 56(2):89-93. PubMed ID: 24056641
[TBL] [Abstract][Full Text] [Related]
4. The use of isotypic control antibodies in the analysis of CD3+ and CD3+, CD4+ lymphocyte subsets by flow cytometry. Are they really necessary?
Sreenan JJ; Tbakhi A; Edinger MG; Tubbs RR
Arch Pathol Lab Med; 1997 Feb; 121(2):118-21. PubMed ID: 9126036
[TBL] [Abstract][Full Text] [Related]
5. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.
Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F
Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
Tomsová M; Melichar B; Sedláková I; Steiner I
Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
[TBL] [Abstract][Full Text] [Related]
7. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
[TBL] [Abstract][Full Text] [Related]
8. Three-color supplement to the NIAID DAIDS guideline for flow cytometric immunophenotyping.
Nicholson J; Kidd P; Mandy F; Livnat D; Kagan J
Cytometry; 1996 Sep; 26(3):227-30. PubMed ID: 8889396
[No Abstract] [Full Text] [Related]
9. Automatic multiparameter fluorescence imaging for determining lymphocyte phenotype and activation status in melanoma tissue sections.
Dow AI; Shafer SA; Kirkwood JM; Mascari RA; Waggoner AS
Cytometry; 1996 Sep; 25(1):71-81. PubMed ID: 8875056
[TBL] [Abstract][Full Text] [Related]
10. "Virtual flow cytometry" of immunostained lymphocytes on microscopic tissue slides: iHCFlow tissue cytometry.
Cualing HD; Zhong E; Moscinski L
Cytometry B Clin Cytom; 2007 Jan; 72(1):63-76. PubMed ID: 17133379
[TBL] [Abstract][Full Text] [Related]
11. Stereologic estimation of the total numbers, the composition and the anatomic distribution of lymphocytes in cone biopsies from patients with stage I squamous cell carcinoma of the cervix uteri.
Nedergaard BS; Nielsen K; Nyengaard JR; Ladekarl M
APMIS; 2007 Dec; 115(12):1321-30. PubMed ID: 18184401
[TBL] [Abstract][Full Text] [Related]
12. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.
Ladoire S; Arnould L; Apetoh L; Coudert B; Martin F; Chauffert B; Fumoleau P; Ghiringhelli F
Clin Cancer Res; 2008 Apr; 14(8):2413-20. PubMed ID: 18413832
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fluorescein and phycoerythrin conjugates for quantifying CD20 expression on normal and leukemic B-cells.
Wang L; Abbasi F; Gaigalas AK; Vogt RF; Marti GE
Cytometry B Clin Cytom; 2006 Nov; 70(6):410-5. PubMed ID: 16967494
[TBL] [Abstract][Full Text] [Related]
14. Morphological and immunohistochemical features of tumor infiltrating lymphocytes (TIL) in carcinomas. Note I.
Ardeleanu C; Hălălău F; Benea L; Butur G; Nicolau N; Nicolaescu E; Stăniceanu F; Zurac S
Rom J Morphol Embryol; 1998; 44(1-4):191-9. PubMed ID: 15678863
[TBL] [Abstract][Full Text] [Related]
15. Presence of CD3+ tumor infiltrating lymphocytes is significantly associated with good prognosis in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Srivastava AN; Makker A; Goel MM
Indian J Cancer; 2013; 50(3):239-44. PubMed ID: 24061465
[TBL] [Abstract][Full Text] [Related]
16. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer.
Sheu BC; Kuo WH; Chen RJ; Huang SC; Chang KJ; Chow SN
Breast; 2008 Dec; 17(6):604-10. PubMed ID: 18656354
[TBL] [Abstract][Full Text] [Related]
18. CD8+ lymphocytes and apoptosis in typical and atypical medullary carcinomas of the breast.
Nurlaila I; Telisinghe PU; Ramasamy R
Immunol Lett; 2013; 156(1-2):123-6. PubMed ID: 24120509
[TBL] [Abstract][Full Text] [Related]
19. Iterative restaining as a pivotal tool for n-color immunophenotyping by slide-based cytometry.
Laffers W; Mittag A; Lenz D; Tárnok A; Gerstner AO
Cytometry A; 2006 Mar; 69(3):127-30. PubMed ID: 16479595
[TBL] [Abstract][Full Text] [Related]
20. Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast.
Coronella JA; Spier C; Welch M; Trevor KT; Stopeck AT; Villar H; Hersh EM
J Immunol; 2002 Aug; 169(4):1829-36. PubMed ID: 12165506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
